- Home
- TSHA vs ASPN Comparison
TSHA vs ASPN Comparison
Compare TSHA & ASPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- ASPN
- Stock Information
- Founded
- TSHA 2019
- ASPN 2001
- Country
- TSHA United States
- ASPN United States
- Employees
- TSHA N/A
- ASPN 554
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- ASPN RETAIL: Building Materials
- Sector
- TSHA Health Care
- ASPN Consumer Discretionary
- Exchange
- TSHA Nasdaq
- ASPN Nasdaq
- Market Cap
- TSHA 728.4M
- ASPN 544.4M
- IPO Year
- TSHA 2020
- ASPN 2014
- Fundamental
- Price
- TSHA $3.36
- ASPN $6.62
- Analyst Decision
- TSHA Strong Buy
- ASPN Strong Buy
- Analyst Count
- TSHA 7
- ASPN 8
- Target Price
- TSHA $8.71
- ASPN $19.29
- AVG Volume (30 Days)
- TSHA 3.5M
- ASPN 1.8M
- Earning Date
- TSHA 08-12-2025
- ASPN 11-05-2025
- Dividend Yield
- TSHA N/A
- ASPN N/A
- EPS Growth
- TSHA N/A
- ASPN N/A
- EPS
- TSHA N/A
- ASPN N/A
- Revenue
- TSHA $8,098,000.00
- ASPN $397,175,000.00
- Revenue This Year
- TSHA N/A
- ASPN N/A
- Revenue Next Year
- TSHA N/A
- ASPN $8.56
- P/E Ratio
- TSHA N/A
- ASPN N/A
- Revenue Growth
- TSHA N/A
- ASPN 11.18
- 52 Week Low
- TSHA $1.05
- ASPN $4.16
- 52 Week High
- TSHA $3.40
- ASPN $30.24
- Technical
- Relative Strength Index (RSI)
- TSHA 70.13
- ASPN 43.13
- Support Level
- TSHA $2.79
- ASPN $6.29
- Resistance Level
- TSHA $2.99
- ASPN $7.23
- Average True Range (ATR)
- TSHA 0.16
- ASPN 0.29
- MACD
- TSHA 0.03
- ASPN -0.07
- Stochastic Oscillator
- TSHA 93.71
- ASPN 29.95
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About ASPN Aspen Aerogels Inc.
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.